The Efficacy of Sodium-glucose Co-transporter 2 Inhibitor or Dipeptidyl Peptidase-4 Inhibitor in Type 2 Diabetes Patients With Premix Insulin
Clinical trial NCT03458715 · UNKNOWN
Trial details
- NCT number
- NCT03458715
- Sponsor
- Mackay Memorial Hospital
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-21
- Primary completion
- 2018-09-21
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.